Active ingredient
Concizumab
3 finished FDA listings contain Concizumab as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- CONCIZUMAB
- Dosage forms
- Injection, Solution
- Routes
- Subcutaneous
- Manufacturers / labelers
- 1
- Strengths listed
- 100 mg/ml · 40 mg/ml
- Brand names in FDA listings
- Alhemo
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2708333
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 761315 | NOVO NORDISK INC | 2024-12-20 | 3 |
Official labeling on DailyMed
- ALHEMO (CONCIZUMAB) INJECTION, SOLUTION [NOVO NORDISK] · version 6 · 2025-08-15
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.